NCT02926326View on ClinicalTrials.gov

The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Interaction

Interventions

DRUG

BCT197

A single dose of BCT197

DRUG

Azithromycin

3 daily doses of Azithromycin

Trial Locations (1)

BT2 7BA

BioKinetic Europe Ltd, Belfast

Sponsors

Lead Sponsor

Mereo BioPharma

All Listed Sponsors

lead

Mereo BioPharma

INDUSTRY

NCT02926326 - The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter